In Japan, there have been reported cases of death due to pulmonary embolism after stem cell administration (the causal relationship is unknown), and in the United States, cases of blindness due to intraorbital administration.
At our hospital, we have set strict standards for cell quality control and administration methods, and we prioritize safety when providing treatment.
To date, we have provided treatment to over 16,000 patients, with not a single reported case of serious complications.
Are there any serious complications?
Are there any serious complications?
In Japan, there have been reported cases of death due to pulmonary embolism after stem cell administration (the causal relationship is unknown), and in the United States, cases of blindness due to intraorbital administration.
At our hospital, we have set strict standards for cell quality control and administration methods, and we prioritize safety when providing treatment.
To date, we have provided treatment to over 16,000 patients, with not a single reported case of serious complications.
